Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-06-23
1995-12-26
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514198, 514199, 424450, A61K 3143, A61K 3722
Patent
active
054788196
ABSTRACT:
A method of and composition for treating a Helicobacter pylori infection in a mammal. The method comprises administering to said mammal orally a therapeutically effective amount of a Helicobacter pylori eradicating antibiotic and a phospholipid. The composition comprises a Helicobacter pylori eradicating antibiotic and a phospholipid.
REFERENCES:
patent: 4918063 (1990-04-01), Lichtenberger
patent: 5000958 (1991-03-01), Fountain et al.
patent: 5077057 (1991-12-01), Szoka, Jr.
patent: 5169637 (1992-12-01), Lenk et al.
patent: 5196205 (1993-03-01), Borody
patent: 5229380 (1993-07-01), Harris
Kivinen et al., Kivinen, Phospholipids, Milchwissenschaft 47(11) 1992, pp. 694-696.
Kivinen et al., Kivinen, Phospholipids, Milchwissenschaft 47(9) 1992, pp. 573-575.
Kivinen Anneli
Tarpila Simo
Henley III Raymond
Tarpila Simo
LandOfFree
Phospholipid composition and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipid composition and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipid composition and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369294